Farsta, Sweden

William Stafford

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.2

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of William Stafford

Introduction

William Stafford is a notable inventor based in Farsta, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cancer. With a total of four patents to his name, Stafford's work is recognized for its potential impact on medical science.

Latest Patents

Among his latest patents are two significant innovations. The first patent involves sulfinylpyridines and their use in the treatment of cancer. This patent provides compounds of formula I or pharmaceutically-acceptable salts thereof, wherein L, R, R, R, and n have meanings provided in the description. These compounds are deemed useful in the treatment of various cancers. The second patent focuses on heterocyclylsulfonyl-substituted pyridines and their application in cancer treatment. Similar to the first, this patent also provides compounds of formula I or pharmaceutically-acceptable salts thereof, with specific meanings for L, R, R, R, and X as described. These compounds are also recognized for their utility in combating cancer.

Career Highlights

William Stafford has established a commendable career in the pharmaceutical industry. His work at Oblique Therapeutics AB has positioned him as a key player in the development of innovative cancer treatments. His dedication to research and development has led to advancements that could significantly benefit patients.

Collaborations

Stafford collaborates with talented individuals in his field, including Benjamin Pelcman and Edgars Suna. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

William Stafford's contributions to cancer treatment through his patents and collaborations highlight his importance in the pharmaceutical industry. His innovative spirit continues to drive advancements that may lead to better therapeutic options for patients facing cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…